Actionable news
All posts from Actionable news
Actionable news in VNDA: Vanda Pharmaceuticals Inc.,

Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q3 2015 Results - Earnings Call Transcript


Welcome to the Q3 2015 Vanda Pharmaceuticals Inc. Earnings Conference Call. My name is Anna, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note that this conference is being recorded.

I will now turn the call over to Jim Kelly, Vanda’s Senior Vice President and Chief Financial Officer. Mr. Kelly, you may begin.

Jim Kelly - SVP and CFO

All right. Thank you, Anna. Good afternoon and thank you for joining us to discuss Vanda Pharmaceuticals' third quarter 2015 performance. Our third quarter 2015 results were released this afternoon and are available on the SEC EDGAR system and on our website, In addition, we’re providing live and archived versions of this conference call on our website.

Joining me on today’s call is Dr. Mihael Polymeropoulos, our President and CEO and Tom Kibbs, our SVP and Chief Commercial Officer. Following my introductory remarks, Dr. Polymeropoulos will update you on our ongoing...